Events Archive
Cervical Screening in low resource Settings
This presentation will focus on the recent history of prevention and management of cervical cancer and will provide a perspective on the direction that future cervical cancer prevention programs will take, particularly for low-resource settings, in coming years.
Hereditary Cancer Clinic event | 20th Anniversary Symposium
The Hereditary Cancer Clinic (“HCC”) at Prince of Wales Hospital, Randwick celebrate their 20th anniversary this year by hosting a symposium ‘Cancer Predisposition Genes – What Clinicians need to Know’ Saturday 25 October.
The Translational Cancer Research Network are working with the HCC to facilitate and promote this event aimed at general practitioners (“GP”s) and trainees in medicine and surgery.
Modelling HPV prevention and cervical screening: Quantitative Research Methods Seminar
We provide a short overview of a comprehensive HPV and cervical cancer model platform (POLICY1) that has been used to perform multiple evaluations of HPV and cervical screening, including evaluations for national reviews of cervical screening in Australia, England and New Zealand. We will provide three short case studies to illustrate some different applications of the platform. Megan Smith will discuss the impact of heterogeneity on estimates of the effect of male HPV vaccination. Kate Simms will discuss an evaluation of the optimal age of ceasing cervical screening.
UNFED meeting
UNSW Network of Faculty Educational Developers (UNFED)
UNSW Medicine is hosting the next UNFED meeting
We have an excellent line-up of local best practice in blended learning:
1. Improving feedback quality, consistency and usefulness in postgraduate programs in the School of Public Health and Community Medicine. Dr Lesley Halliday, SPHCM
2. Analytics for Retrieving Feedback on Skills Development. Dr Patsie Polly, SOMS
3. Introducing the User Engagement Scale. A/Prof Gary Velan, SOMS
School of Psychiatry Academic Forum Series 2014
Title: An inflammatory view of schizophrenia
Speaker: Dr Stuart Fillman
Chair: Marie-Paule Austin
Synthesizing genetic markers for incorporation into clinical risk prediction tools: Quantitative Research Methods Seminar
Clinical risk prediction tools built on standard risk factors are important devices for many different diseases. Newly discovered genetic and high-dimensional-omic markers, such as single nucleotide polymorphisms (SNPs) and gene expressions, have the potential to increase the practical utility of clinical risk prediction tools. Typically, these markers are assessed among multiple large case-control studies but not in the original cohorts used to build the existing risk prediction tools, making their incorporation into those tools complicated.
AIHI Lunchtime Seminar Series with guest speaker Professor Dean Sittig
Future Directions for Patient Safety through Health IT
Health and Biomedical Big Data for Translational Research
Professor Jack Li of the College of Medical Science and Technology (CoMST) at Taipei Medical University is currently visiting the Translational Cancer Research Network (TCRN) to help shape a new translational Cancer Bioinformatics course which is currently being developed by TCRN and UNSW.. His seminar will examine the availability of tools and data sets that can facilitate this transformation and will present examples and evidence of how this transformation will change the way we look at biomedical research forever.
Quantitative Research Methods Seminar: Clinically driven meta-analysis simulations and their performance
Meta-analysis is a commonly used technique to formally combine results of multiple randomized trials, yet controversy regarding its use remains, often involving the role of heterogeneity, both clinical and statistical. We aim to comprehensively explore meta-analysis performance in a clinically driven simulated model and the impact on performance of common dimensions of clinical heterogeneity. We model varying size and number of RCTs using different means and distributions of background event risk and relative risk reduction.
AIHI Lunchtime Seminar Series: False as Water
Fluid resuscitation is the second most common intervention in the intensive care unit, following the administration of supplemental oxygen. Notwithstanding, the physiological principles, clinical indications and patient-centred outcomes for this ubiquitous therapy remain a matter of debate. Recent large randomized, controlled trials in Scandinavia and Australia/New Zealand have provided robust evidence to guide clinical practice.